New insulin enters first human tests
NCT ID NCT07242664
Summary
This is an early-stage study to test a new long-acting insulin called GZR33 in people with type 1 diabetes. It will compare how well GZR33 controls blood sugar and how safe it is compared to an existing insulin (degludec). The study will involve 12 adults to see how the body processes the new insulin and to estimate its strength.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Profil
RECRUITINGNeuss, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Profil Institut
RECRUITINGNeuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.